Angiomax Generic From Hospira Might Launch At-Risk Launch In 2015

District Court upholds validity of TMC’s process patents for its anticoagulant but finds Hospira does not infringe them.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America